261 related articles for article (PubMed ID: 30706395)
41. Production, Purification, and Titration of First-Generation Adenovirus Vectors.
Kratzer RF; Kreppel F
Methods Mol Biol; 2017; 1654():377-388. PubMed ID: 28986806
[TBL] [Abstract][Full Text] [Related]
42. Generation of recombinant adeno-associated virus vectors by a complete adenovirus-mediated approach.
Zhang X; Li CY
Mol Ther; 2001 May; 3(5 Pt 1):787-92. PubMed ID: 11356083
[TBL] [Abstract][Full Text] [Related]
43. Longevity of adenovirus vector immunity in mice and its implications for vaccine efficacy.
Sayedahmed EE; Kumari R; Shukla S; Hassan AO; Mohammed SI; York IA; Gangappa S; Sambhara S; Mittal SK
Vaccine; 2018 Oct; 36(45):6744-6751. PubMed ID: 30266488
[TBL] [Abstract][Full Text] [Related]
44. Comparative Study of Adeno-associated Virus, Adenovirus, Bacu lovirus and Lentivirus Vectors for Gene Therapy of the Eyes.
Kalesnykas G; Kokki E; Alasaarela L; Lesch HP; Tuulos T; Kinnunen K; Uusitalo H; Airenne K; Yla-Herttuala S
Curr Gene Ther; 2017; 17(3):235-247. PubMed ID: 28982327
[TBL] [Abstract][Full Text] [Related]
45. Adenovirus vectors and subviral particles for protein and peptide delivery.
Kron MW; Kreppel F
Curr Gene Ther; 2012 Oct; 12(5):362-73. PubMed ID: 22845888
[TBL] [Abstract][Full Text] [Related]
46. Capsid Engineering of Adenovirus Vectors: Overcoming Early Vector-Host Interactions for Therapy.
Hagedorn C; Kreppel F
Hum Gene Ther; 2017 Oct; 28(10):820-832. PubMed ID: 28854810
[TBL] [Abstract][Full Text] [Related]
47. Adenovirus as an integrating vector.
Mitani K; Kubo S
Curr Gene Ther; 2002 May; 2(2):135-44. PubMed ID: 12109211
[TBL] [Abstract][Full Text] [Related]
48. Targeted adenovirus vectors.
Mizuguchi H; Hayakawa T
Hum Gene Ther; 2004 Nov; 15(11):1034-44. PubMed ID: 15610604
[TBL] [Abstract][Full Text] [Related]
49. Adenovirus vectors for gene delivery.
Benihoud K; Yeh P; Perricaudet M
Curr Opin Biotechnol; 1999 Oct; 10(5):440-7. PubMed ID: 10508634
[TBL] [Abstract][Full Text] [Related]
50. EGTA enhancement of adenovirus-mediated gene transfer to mouse tracheal epithelium in vivo.
Chu Q; St George JA; Lukason M; Cheng SH; Scheule RK; Eastman SJ
Hum Gene Ther; 2001 Mar; 12(5):455-67. PubMed ID: 11268280
[TBL] [Abstract][Full Text] [Related]
51. Enhanced mucosal immunoglobulin A response of intranasal adenoviral vector human immunodeficiency virus vaccine and localization in the central nervous system.
Lemiale F; Kong WP; Akyürek LM; Ling X; Huang Y; Chakrabarti BK; Eckhaus M; Nabel GJ
J Virol; 2003 Sep; 77(18):10078-87. PubMed ID: 12941918
[TBL] [Abstract][Full Text] [Related]
52. Gene transfer into neural cells in vitro using adenoviral vectors.
Southgate TD; Kingston PA; Castro MG
Curr Protoc Neurosci; 2001 May; Chapter 4():Unit 4.23. PubMed ID: 18428483
[TBL] [Abstract][Full Text] [Related]
53. Helper virus-free gutless adenovirus (HF-GLAd): a new platform for gene therapy.
Liu J; Seol DW
BMB Rep; 2020 Nov; 53(11):565-575. PubMed ID: 32958121
[TBL] [Abstract][Full Text] [Related]
54. Viral vectors for the treatment of alcoholism: use of metabolic flux analysis for cell cultivation and vector production.
Martinez V; Gerdtzen ZP; Andrews BA; Asenjo JA
Metab Eng; 2010 Mar; 12(2):129-37. PubMed ID: 19815088
[TBL] [Abstract][Full Text] [Related]
55. Use of a chimeric adenovirus vector enhances BMP2 production and bone formation.
Olmsted-Davis EA; Gugala Z; Gannon FH; Yotnda P; McAlhany RE; Lindsey RW; Davis AR
Hum Gene Ther; 2002 Jul; 13(11):1337-47. PubMed ID: 12162816
[TBL] [Abstract][Full Text] [Related]
56. Adenovirus-mediated in vivo gene transfer.
Brody SL; Crystal RG
Ann N Y Acad Sci; 1994 May; 716():90-101; discussion 101-3. PubMed ID: 7517653
[TBL] [Abstract][Full Text] [Related]
57. Methods for construction of adenovirus vectors.
Graham FL; Prevec L
Mol Biotechnol; 1995 Jun; 3(3):207-20. PubMed ID: 7552690
[TBL] [Abstract][Full Text] [Related]
58. Establishment and validation of new complementing cells for production of E1-deleted adenovirus vectors in serum-free suspension culture.
Gilbert R; Guilbault C; Gagnon D; Bernier A; Bourget L; Elahi SM; Kamen A; Massie B
J Virol Methods; 2014 Nov; 208():177-88. PubMed ID: 25159033
[TBL] [Abstract][Full Text] [Related]
59. Human amniocyte-derived cells are a promising cell host for adenoviral vector production under serum-free conditions.
Silva AC; Simão D; Küppers C; Lucas T; Sousa MF; Cruz P; Carrondo MJ; Kochanek S; Alves PM
Biotechnol J; 2015 May; 10(5):760-71. PubMed ID: 25943527
[TBL] [Abstract][Full Text] [Related]
60. Adenovirus vector-based vaccines for human immunodeficiency virus type 1.
Barouch DH; Nabel GJ
Hum Gene Ther; 2005 Feb; 16(2):149-56. PubMed ID: 15761255
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
